To test this theory, they identified a short peptide that inhibits the binding of cyclin A-cdk2 to E2F and used it to
treat cultured cells.
Not exact matches
EGFR / WT and KO
cells were cultured overnight and starved for 24 h. Cells were treated with capsaicin (50 μmol / L) for 30 min and then TPA (20 ng / mL) for 2 h. Cells were lysed and cox - 2 mRNA levels were analyzed by RT -
cells were
cultured overnight and starved for 24 h.
Cells were treated with capsaicin (50 μmol / L) for 30 min and then TPA (20 ng / mL) for 2 h. Cells were lysed and cox - 2 mRNA levels were analyzed by RT -
Cells were
treated with capsaicin (50 μmol / L) for 30 min and then TPA (20 ng / mL) for 2 h.
Cells were lysed and cox - 2 mRNA levels were analyzed by RT -
Cells were lysed and cox - 2 mRNA levels were analyzed by RT - PCR.
They found high levels of the regulatory T -
cells in patients
treated with post-transplant cyclophosphamide, and lab -
cultured cells survived cyclophosphamide treatment.
Finally, in
cell cultures and animals, overexpressing the hormone could produce something that looks like cancer, and that would shrink when
treated with an IGF - 1R blocker.
«If we win, the entire regulatory structure for autologous
cell processing, with or without
culture, will be rewritten such that any physician using good practices and
treating patients responsibly can use stem
cells as part of his or her medical practice,» he says.
Although such harvested
cells could be
cultured as say, liver
cells for
treating hepatitis or dopamine - producing
cells for Parkinson's, the resulting transplants would likely be rejected by patients» immune systems.
Despite a lack of rigorous clinical trials to test safety or efficacy, a ban of the treatment by health authorities, and a lack of peer review by the scientific community, the privately funded Stamina Foundation has been using
cultured mesenchymal stem
cells that have been exposed to putative conditions that favour neuronal differentiation to
treat different diseases in severely or terminally ill patients.
«We've taken white
cells from his body, put them in a
culture with malignant
cells, and they gobble them up,» says Michael O'Rourke, who is
treating the patient.
In this study, Nicchitta and his colleagues
treated tissue
culture cells with a stress - inducing agent called thapsigargin.
In animal and
cell culture studies, the drug inhibited growth both in estrogen - dependent breast cancer
cells and in
cells that had developed resistance to the anti-estrogen tamoxifen and / or to the aromatase inhibitors, two of the most widely used types of drugs to prevent and
treat estrogen - dependent breast cancer.
Next, Grima looked at
cell death in
cultured neurons with a healthy or a mutant form of Huntingtin, or with a mutant form of Huntingtin that was
treated with small amounts of an experimental drug called KPT - 350, one that prevents a nuclear export protein, Exportin - 1, from shuttling proteins and RNA out of the nucleus.
An important approach in advanced cancer medicine is to
treat cancer using a patient's immune
cells after first arming the
cells against the tumor in
culture.
The researchers verified their findings by
treating cultured pancreatic cancer
cells with recombinant MMP3.
A new study shows coibamide A has potent anti-cancer activity in mice and
cell cultures that model brain tumors and triple negative breast cancer, two of the most aggressive and difficult - to -
treat types of cancer.
By
culturing human stem
cells in this manner and
treating them with specific signaling molecules, the investigators were able to guide
cells through key processes involved in the development of the human inner ear.
Normally, CD4
cells will start dividing when they are
treated with certain proteins in a
culture dish.
At the time, his varied interests — in the use of skin
cell culture to
treat burns, in human tissue
cultures, and in biopharmaceutical production — led him to do his final year, 6 - month project on
culture in a bioreactor.
Furthermore, in control
cultures that were untransduced or
treated with R5 - ZFNs, viral titers exponentially increased until extensive
cell death began approximately 8 — 10 days post infection.
An oral drug used to
treat an illness unrelated to HIV eradicated infectious HIV - producing
cells in lab
cultures while sparing uninfected
cells — and suppressed the virus in patients during treatment and for at least eight weeks after the drug was stopped, according to results of a clinical pilot trial and researchers at Rutgers University and Dartmouth College.
We also found that after 19 days post-HIV infection, reduced but significant
cell growth was detectable in several of the HIV - infected control
cultures, untransduced and
treated with R5 - ZFNs.
For the time course study,
cells were
treated with 20 μM of EGCG for 12, 24, 48, 72, or 144 h. Human colon cancer
cell line HT - 29 and prostate cancer
cell line PC3 were obtained from American Type
Culture Collection (Manassas, VA), and were grown in McCoy's 5A and RPMI 1640 containing 10 % fetal bovine serum, respectively.
However, this is unlikely given that the frequency of in - frame mutations remained stable over nearly four weeks in
culture, that there was no significant increase in
cell death between control
cultures and those
treated with X4 - ZFNs, and that the most common in - frame mutant was not expressed on the
cell surface and thus can not maintain functionality.
In contrast, in
cultures treated with X4 - ZFNs viral titers steadily decreased after peak viremia while
cell growth remained exponential suggesting there was not significant viral production (data not shown).
To determine the causes of this depletion, the investigators
treated neurons grown in
cell culture with amyloid - beta proteins, which accumulate in Alzheimer brains.
None of these toxic effects were observed when the same
cells were
treated with
culture medium from non-senescent astrocytes that had not been subjected to paraquat.7
To determine the effect of the conditioned medium on NGF - induced neurite outgrowth, PC12
cells were dissociated and plated on polyornithine - coated tissue
culture dishes in the following conditions: 1) HT22 conditioned medium, 2) J147
treated HT22 conditioned medium, 3) DMEM alone plus J147, 4) DMEM plus NGF at 50 nanograms per ml, 5) J147
treated HT22 conditioned medium pre-incubated for one hour with 10 μg / ml anti-NGF and N2 supplement (Invitrogen).
Briefly, NHLF
cells were grown in 96 - well CoStar tissue
culture plates (4,000
cells per well) and either subjected to siRNA gene silencing or directly
treated with compounds for 51hours in 100 µL complete medium per well.
Confluent HFF
cells were
treated with irradiation of 55 Gy and plated onto
culture dishes (1 × 105 per 2.89 cm2).
ROS levels, as measured by the proportion of
cells that stained positive for CellROX, increased from an average of 8.1 % in
cultures treated with DMSO to 78 % in
cultures treated with curcumin.
Where indicated,
cells were
treated daily with 10 or 200 ng / ml of growth differentiation factor (GDF) 5 (GDF5)(Biopharm GmbH), which are maximal saturating concentrations in primary and SH - SY5Y
cell cultures respectively [17,41].
Because ATRA could cause IFNα synthesis and secretion in NB4
cells by up - regulating IRF - 1 (23), we thus quantitated the IFNα in
culture supernatant of ATRA -
treated NB4
cells.
Cells were then plated in 24 - well tissue
culture treated plates and incubated in a humidified 5 % CO2 incubator at 37 °C.
For induction of differentiation to mature endothelial
cells, EPCs were plated at a high
cell density (8 × 104
cells / cm2) on tissue
culture treated flasks.
HES3
cultures were
treated with 10 µM Y - 27632 (ROCK inhibitor, Axxora LLC, San Diego, CA) for 1 hour prior to dissociation to single
cells using TrypLE ™ (Invitrogen, cat.
To eliminate the possibility of any undifferentiated
cells in the
cultures accounting for this observation, DMSO - differentiated
cells were
treated with the anti-proliferative agent cytosine arabinosidase (Ara - C), starting two days after aggregate plating.
Therefore, twelve day old, DMSO - differentiated, Ara - C
treated P19
cultures were incubated with the proteasome inhibitors MG - 132 and lactacystin for four hours; this was sufficient to rescue Oct4 protein expression (Figure 1D), suggesting that these
cells do indeed synthesize new Oct4 protein.
HEK293T
cells were seeded at 2 × 107
cells in 15 - cm tissue
culture plates and
cells were
treated with 20 mM LiCl for 7 hr.